Most cannabis flower on the European market would fail a human-consumption standard, Fundación CANNA finds – MMJDaily
A new study from Fundación CANNA, a respected European cannabis research organization, has found that the majority of cannabis flower products currently sold across Europe would not meet the safety standards required for human consumption. The findings raise serious concerns about product quality and consumer safety in a market that continues to grow rapidly.
The research looked at cannabis flower samples from various parts of the European market and tested them against benchmarks used for products intended for people to consume. A large portion of those samples fell short, which points to a significant gap between what is being sold and what would be considered safe and acceptable under stricter guidelines.
For CBD consumers, this is an important reminder that not all hemp and cannabis products are created equal. Without consistent regulation and testing standards across European countries, shoppers may unknowingly purchase products that do not meet basic quality thresholds. Choosing products from brands that offer third-party lab testing and transparent sourcing remains one of the best ways for consumers to protect themselves.
This kind of research plays a valuable role in pushing the industry toward higher standards and better accountability. As the CBD and hemp markets continue to expand in Europe, findings like these could influence future regulations and how products are tested before reaching store shelves. Readers who want to dig deeper into the study and its findings can check out the full story at MMJDaily for complete details.
